pyrotinib tablet

DRUG2 trials

Sponsors

Jiangsu HengRui Medicine Co., Ltd.

Conditions

HER2-positive Recurrent / Metastatic Breast CancerHealthy Subjects

Phase 1

Effect of Itraconazole on the Pharmacokinetics of Pyrotinib in Healthy Subjects

CompletedNCT04479891

Jiangsu HengRui Medicine Co., Ltd.Healthy Subjects

Start: 2019-09-18End: 2019-11-30Updated: 2020-07-21

Effect of Montmorillonite Power or Loperamide on the Pharmacokinetics of Pyrotinib in Healthy Subjects

CompletedNCT05252546

Jiangsu HengRui Medicine Co., Ltd.HER2-positive Recurrent / Metastatic Breast Cancer

Start: 2022-03-08End: 2022-08-02Updated: 2022-12-23

Related Papers

Evaluation of the pharmacokinetic interactions of montmorillonite powder or loperamide on pyrotinib in healthy volunteers

Frontiers in Pharmacology2025-05-12